BioGenCell’s mission is to develop an innovative technology platform that will enable the rapid creation of easy-to-use and cost-effective treatments for a wide range of degenerative diseases using highly standardized therapies derived from adult stem cells.
Dr. Michael Frogel
Dr. Frogel is an Associate Professor of Pediatrics at the Albert Einstein College of Medicine, Principal Investigator for the New York City Pediatric Disaster Coalition (PDC) and Medical Director of the Pediatric Disaster Mental Health Initiative at Maimonides Medical Center. He has previously served as Chairman of Pediatrics at Nassau University Medical Center and Chief of General Pediatrics, Urgent Care and Emergency Medicine at Cohen Children’s Medical Center of the NSLIJ Health System. Dr. Frogel’s main areas of interest are pediatric emergency preparedness, child advocacy, sports medicine and weight management, preventive pediatrics and stem cell research. He has received millions of dollars in grants and created special programs for Pediatric Urgent Care, Women Infants and Children (WIC, Nutrition), Childhood Obesity and Sports Medicine, Autism and Child Abuse during his extensive career in building healthcare systems. Since 2008 he has served as Principal Investigator for the NY City Department of Health, US Health and Human Services, PDC Grant encompassing pediatric emergency preparedness for New York City. Dr. Frogel is recognized as a world expert on Emergency and Disaster Preparedness. He coordinates a yearly course in Israel on Emergency Preparedness. He has frequently visited Israeli cities under attack and has spearheaded campaigns to build shelters at schools and playgrounds. Dr. Frogel is currently applying his expertise in HealthCare System Management to the development of a revolutionary stem cell treatment for vascular diseases that promises to regenerate blood vessels restore tissue function and return patients from disability to full function.